Advanced Therapeutic Antibody Discovery with Multiplexed Screening
White Paper Nov 25, 2018
Antibody-based therapeutics are the fastest growing and most successful therapeutic modality for treating numerous diseases including cancer, autoimmune disorders and infectious disease.
Multiplexed high throughput screening has become an essential component in the discovery of therapeutic antibodies.
Download this whitepaper to learn:
• How to perform multiplexed screens for antibody binding to either cell surface or to circulating target antigens.
• How the Intellicyt® iQue Screener PLUS platform can be used to carry out high content assays to evaluate the effects of lead candidates in multiplexed cell based and secreted protein assays.
Related White Papers
The small footprint and self-contained design make the Epsilon 1 an ideal analytical solution for process control to be placed close to the production line.
READ MOREDownload this whitepaper to discover the current research trends across the seven hallmarks of cancer, and how live-cell analysis is enhancing our understanding of the biological mechanisms underlying cancer behaviors.
READ MOREHigh throughput characterization systems can greatly accelerate discovery programs. Download this whitepaper to discover the key considerations for automated Octet assays.
READ MORELike what you just read? You can find similar content on the communities below.
Analysis & Separations Cancer Research Cell Science Genomics Research Proteomics & Metabolomics Immunology & MicrobiologyTo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE
